Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convalescent Plasma as a Treatment for Patients With Severe COVID-19 Disease

NCT04542967 is registered in ClinicalTrials.gov with Hospital Central Militar as lead sponsor.

NCT NCT04542967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04542967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convalescent Plasma as a Treatment for Patients With Severe COVID-19 Disease
Lead sponsor
Hospital Central Militar
Phase
Phase 2
Overall status
Completed
Start date
June 23, 2020
Completion date
September 30, 2020
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe covid-19 disease